PEAK6
ABBV icon

PEAK6’s AbbVie ABBV Stock Holding History

PEAK6’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.65M Sell
21,400
-159,100
-88% -$35.3M 0.01% 930
2025
Q4 		$41.2M Buy
180,500
+18,000
+11% +$4.1M 0.08% 207
2025
Q3 		$37.6M Buy
162,500
+139,600
+610% +$28.4M 0.06% 251
2025
Q2 		$4.25M Sell
22,900
-5,400
-19% -$1M 0.01% 1046
2025
Q1 		$5.93M Sell
28,300
-12,800
-31% -$2.49M 0.01% 832
2024
Q4 		$7.3M Buy
+41,100
New +$7.56M 0.02% 712

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PEAK6's ABBV Position: Q4 2025 in Review

PEAK6 sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 2 shares — an estimated $456 sold.

PEAK6 first reported a position in ABBV in Q4 2024 and held it in 3 quarters. The position peaked at $1.63M in Q4 2024. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • PEAK6 reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • PEAK6 sold 2 AbbVie shares in Q4 2025, an estimated $456.
  • PEAK6 first reported a position in AbbVie in Q4 2024 and held it in 3 quarters.
  • PEAK6's AbbVie position peaked at $1.63M in Q4 2024.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.